SEI Investments’s Novavax NVAX Stock Holding History

SEI Investments’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$190K	Hold	20,180	–	–	﹤0.01%	3053
2026 Q1	$164K	Buy	20,180 +33	+0.2%	+$299	﹤0.01%	3009
2025 Q4	$135K	Hold	20,147	–	–	﹤0.01%	2977
2025 Q3	$175K	Hold	20,147	–	–	﹤0.01%	2644
2025 Q2	$127K	Hold	20,147	–	–	﹤0.01%	2655
2025 Q1	$129K	Buy	+20,147	New	+$167K	﹤0.01%	2553
2022 Q2	–	Sell	-15,052	Closed	-$1.11M	–	2693
2022 Q1	$1.11M	Sell	15,052 -7,134	-32%	-$636K	﹤0.01%	1780
2021 Q4	$3.12M	Sell	22,186 -8,502	-28%	-$1.46M	0.01%	1373
2021 Q3	$6.35M	Buy	30,688 +11,711	+62%	+$2.58M	0.01%	970
2021 Q2	$4.02M	Sell	18,977 -3,884	-17%	-$712K	0.01%	1197
2021 Q1	$4.14M	Buy	22,861 +20,918	+1,077%	+$4.17M	0.01%	1115
2020 Q4	$217K	Sell	1,943 -1,614	-45%	-$172K	﹤0.01%	2335
2020 Q3	$385K	Sell	3,557 -8,616	-71%	-$1.05M	﹤0.01%	2005
2020 Q2	$1.01M	Buy	+12,173	New	+$466K	﹤0.01%	1560
2018 Q3	–	Sell	-9	Closed	–	–	3132
2018 Q2	$0	Hold	9	–	–	﹤0.01%	3732
2018 Q1	$0	Hold	9	–	–	﹤0.01%	3608
2017 Q4	$0	Hold	9	–	–	﹤0.01%	3437
2017 Q3	$0	Hold	9	–	–	﹤0.01%	3330
2017 Q2	$0	Sell	9 -250	-97%	-$4.91K	﹤0.01%	3221
2017 Q1	$7K	Buy	259 +250	+2,778%	+$6.88K	﹤0.01%	2522
2016 Q4	$0	Sell	9 -528	-98%	-$15.4K	﹤0.01%	3017
2016 Q3	$22K	Buy	537 +528	+5,867%	+$68.2K	﹤0.01%	2258
2016 Q2	$1K	Buy	+9	New	+$1.03K	﹤0.01%	2560
2015 Q4	–	Sell	-5,416	Closed	-$766K	–	2633
2015 Q3	$766K	Buy	+5,416	New	+$1.21M	0.01%	1132

Other funds holding NVAX

SCM

Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

SEI Investments's NVAX Position: Q2 2026 in Review

SEI Investments held its Novavax (NVAX) position steady in Q2 2026 at 20,180 shares worth $190K. The position accounts for ﹤0.01% of the portfolio, ranked #3053.

SEI Investments first reported a position in NVAX in Q3 2015 and has held it in 24 quarters since. The position peaked at $6.35M in Q3 2021. 266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

SEI Investments held 20,180 shares of Novavax worth $190K as of Q2 2026.
SEI Investments left its Novavax share count unchanged in Q2 2026.
Novavax made up ﹤0.01% of SEI Investments's portfolio in Q2 2026, its #3053 holding.
SEI Investments first reported a position in Novavax in Q3 2015 and has held it in 24 quarters since.
SEI Investments's Novavax position peaked at $6.35M in Q3 2021.
266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.